Reconsidering the Algorithm: DME
b'Host: Christina Y. Weng, MD, MBA
\\n\\n Host: Durga Borkar, MD, MMCi
\\n\\n\\n \\n
The approval of new, more durable treatments is an exciting development for the management of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), but how do these therapies and their unique mechanisms stack up outside of clinical trials? Join Dr. Durga Borkar, Dr. Sabin Dang, Dr. Jayanth Sridhar, and Dr. Christina Weng as they discuss these new treatments and the emerging data surrounding their use in the real world.
'